首页> 外文期刊>Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease >Reduction of Ischemia/Reperfusion Injury With Bendavia, a Mitochondria-Targeting Cytoprotective Peptide
【24h】

Reduction of Ischemia/Reperfusion Injury With Bendavia, a Mitochondria-Targeting Cytoprotective Peptide

机译:使用线粒体靶向细胞保护肽Bendavia减少局部缺血/再灌注损伤

获取原文
           

摘要

Background Manifestations of reperfusion injury include myocyte death leading to infarction, contractile dysfunction, and vascular injury characterized by the “no-reflow” phenomenon. Mitochondria-produced reactive oxygen species are believed to be centrally involved in each of these aspects of reperfusion injury, although currently no therapies reduce reperfusion injury by targeting mitochondria specifically.
机译:背景技术再灌注损伤的表现包括导致梗死的心肌细胞死亡,收缩功能障碍和以“无回流”现象为特征的血管损伤。线粒体产生的活性氧被认为与再灌注损伤的各个方面都有关,尽管目前尚无疗法通过特异性靶向线粒体来减轻再灌注损伤。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号